169 related articles for article (PubMed ID: 10417349)
1. Molecular and functional analysis of mouse decay accelerating factor (CD55).
Harris CL; Rushmere NK; Morgan BP
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):821-9. PubMed ID: 10417349
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55).
Hinchliffe SJ; Spiller OB; Rushmere NK; Morgan BP
J Immunol; 1998 Nov; 161(10):5695-703. PubMed ID: 9820551
[TBL] [Abstract][Full Text] [Related]
3. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
[TBL] [Abstract][Full Text] [Related]
4. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
Miwa T; Okada N; Okada H
Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
[TBL] [Abstract][Full Text] [Related]
5. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form.
Song WC; Deng C; Raszmann K; Moore R; Newbold R; McLachlan JA; Negishi M
J Immunol; 1996 Nov; 157(9):4166-72. PubMed ID: 8892654
[TBL] [Abstract][Full Text] [Related]
6. Functional differences among multiple isoforms of guinea pig decay-accelerating factor.
Wang G; Nonaka M; He C; Okada N; Nakashima I; Okada H
J Immunol; 1998 Mar; 160(6):3014-22. PubMed ID: 9510206
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes.
Ohta R; Imai M; Fukuoka Y; Miwa T; Okada N; Okada H
Microbiol Immunol; 1999; 43(11):1045-56. PubMed ID: 10609614
[TBL] [Abstract][Full Text] [Related]
8. Decay-accelerating factor in the periovulatory rat ovary.
Gieske MC; Na GY; Koo Y; Jo M; Curry TE; Ko C
J Endocrinol; 2005 Aug; 186(2):303-13. PubMed ID: 16079256
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms.
Spicer AP; Seldin MF; Gendler SJ
J Immunol; 1995 Sep; 155(6):3079-91. PubMed ID: 7545711
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of novel splicing variants of human decay-accelerating factor.
Osuka F; Endo Y; Higuchi M; Suzuki H; Shio Y; Fujiu K; Kanno R; Oishi A; Terashima M; Fujita T; Gotoh M
Genomics; 2006 Sep; 88(3):316-22. PubMed ID: 16503113
[TBL] [Abstract][Full Text] [Related]
11. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing.
Nonaka M; Miwa T; Okada N; Nonaka M; Okada H
J Immunol; 1995 Sep; 155(6):3037-48. PubMed ID: 7545710
[TBL] [Abstract][Full Text] [Related]
12. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
13. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.
Miwa T; Sun X; Ohta R; Okada N; Harris CL; Morgan BP; Song WC
Immunology; 2001 Oct; 104(2):207-14. PubMed ID: 11683961
[TBL] [Abstract][Full Text] [Related]
14. Effect of tandem forms of DAF(CD55) on complement-mediated xenogeneic cell lysis.
Miyagawa S; Fukuta D; Kitano E; Kobayashi C; Fumimoto Y; Shirasu A; Hattori H; Shirakura R; Fukuzawa M
Xenotransplantation; 2006 Sep; 13(5):433-9. PubMed ID: 16925667
[TBL] [Abstract][Full Text] [Related]
15. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1.
Shenoy-Scaria AM; Kwong J; Fujita T; Olszowy MW; Shaw AS; Lublin DM
J Immunol; 1992 Dec; 149(11):3535-41. PubMed ID: 1385527
[TBL] [Abstract][Full Text] [Related]
17. Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.
Nickells MW; Alvarez JI; Lublin DM; Atkinson JP
J Immunol; 1994 Jan; 152(2):676-85. PubMed ID: 7506731
[TBL] [Abstract][Full Text] [Related]
18. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo.
Moran P; Beasley H; Gorrell A; Martin E; Gribling P; Fuchs H; Gillett N; Burton LE; Caras IW
J Immunol; 1992 Sep; 149(5):1736-43. PubMed ID: 1380537
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
Qian YM; Haino M; Kelly K; Song WC
Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
[TBL] [Abstract][Full Text] [Related]
20. Decay-accelerating factor (DAF/CD55) is a functional active element of the LPS receptor complex.
Heine H; Ulmer AJ; El-Samalouti VT; Lentschat A; Hamann L
J Endotoxin Res; 2001; 7(3):227-31. PubMed ID: 11581575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
